PIA
LXRX icon

Perennial Investment Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Perennial Investment Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1K Hold
10,990
– – ﹤0.01% 506
2025
Q4 		$12.6K Hold
10,990
– – ﹤0.01% 507
2025
Q3 		$14.8K Hold
10,990
– – ﹤0.01% 481
2025
Q2 		$10.4K Buy
+10,990
New +$7.12K ﹤0.01% 472
2024
Q4 		– Sell
-11,600
Closed -$18.2K – 424
2024
Q3 		$18.2K Buy
+11,600
New +$20.7K ﹤0.01% 396

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Perennial Investment Advisors's LXRX Position: Q1 2026 in Review

Perennial Investment Advisors held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 10,990 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Perennial Investment Advisors first reported a position in LXRX in Q3 2024 and has held it in 5 quarters since. The position peaked at $18.2K in Q3 2024. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Perennial Investment Advisors held 10,990 shares of Lexicon Pharmaceuticals worth $17.1K as of Q1 2026.
  • Perennial Investment Advisors left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Perennial Investment Advisors's portfolio in Q1 2026, its #506 holding.
  • Perennial Investment Advisors first reported a position in Lexicon Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Perennial Investment Advisors's Lexicon Pharmaceuticals position peaked at $18.2K in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.